Surgery Outcome Treated by Neo-adjuvant Combination of Oxaliplatin, Irinotecan, Folinic Acid and Fluorouracil (FOLFOXIRI) Regimen in Synchronous Liver Limited Metastasis Colorectal Cancer
N/A
This single arm study aims to evaluate the rate of conversion therapy in pa...
Status
Unknown
Location
Cho Ray hospital- 201 B Nguyen Chi Thanh, District 5
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer
PHASE2
This phase II trial evaluates whether early switching from modified fluorou...
A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma
PHASE2
This is a phase II, single arm, non-randomized, open label study of liposom...